PT - JOURNAL ARTICLE AU - Al Sifri, Saud AU - Al Shammeri, Owayed AU - Al Jaser, Saleh AU - Alkhenizan, Abdullah AU - Shafiurrehman, Atif Bin Shafi AU - Morcos, Bassem AU - Wajih, Sameh AU - Elnahal, Ibrahim AU - Horack, Martin AU - Brudi, Philippe AU - Lautsch, Dominik AU - Ambegaonkar, Baishali AU - Vyas, Ami AU - Baxter, Carl A. AU - Gitt, Anselm K. TI - Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia AID - 10.15537/smj.2018.7.22146 DP - 2018 Jul 01 TA - Saudi Medical Journal PG - 697--704 VI - 39 IP - 7 4099 - http://smj.org.sa/content/39/7/697.short 4100 - http://smj.org.sa/content/39/7/697.full SO - Saudi Med J2018 Jul 01; 39 AB - Objectives: To provide an overview of the extent of hyperlipidemia in very high-risk patients, and how lipid-lowering therapy (LLT) is used in a real-world setting.Methods: In this multicenter observational study, data were collected from LLT-treated patients with stable CHD or an ACS in Saudi Arabia between 2013 and 2014. Individuals were included if they were >18 years and had a full lipid profile available, recorded either prior to the baseline physician visit (CHD patients) or within 24-hours of admission to hospital (ACS patients).Results: A total of 737 patients were included in the study, 597 with stable CHD and 140 with ACS. Few patients in either group had an LDL-C level of <70 mg/dl, which is advocated for very high-risk patients (24.3% and 11.4%, respectively). The median distances to this value were 19.0 mg/dl (CHD) and 25.0 mg/dl (ACS). Low doses of statins were being utilized (31 and 24 mg/day for CHD and ACS, respectively), with only minimal intensification for the ACS patients after hospital admission (41 mg/day at follow-up).Conclusions: Achievement of recommended LDL-C levels was poor for patients with stable CHD or an ACS. Statin intensity was low, indicating huge scope for intensifying the treatment of these very high-risk patients.